Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jul 18, 2019
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aratana Therapeutics, Inc.
| -18.00K |
—
|
—
| -100.00% |
0
|
Jul 18
| |||||||
Aratana Therapeutics, Inc.
| 4.5K |
—
|
—
| +33.33% | 18K |
Jun 6
| |||||||
Aratana Therapeutics, Inc.
| 4.5K |
—
|
—
| +50.00% | 13.5K |
Jul 27
| |||||||
Aratana Therapeutics, Inc.
| 4.5K |
—
|
—
| +100.00% | 9K |
Jun 21
| |||||||
Aratana Therapeutics, Inc.
| 4.5K |
—
|
—
|
∞
| 4.5K |
Jun 24
| |||||||
Aratana Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 18
| |||||||
Aratana Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 27
| |||||||
Aratana Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Theravance Inc
| -3.81K |
$35.01 | -$133,318.08 | -7.25% | 48.75K |
May 29
|
Scheduled
| ||||||
Theravance Inc
| -2.44K |
$37.01 | -$90,415.43 | -4.44% | 52.56K |
May 20
| |||||||
Theravance Inc
|
0
|
$37.17 | -$102,096.57 |
—
| 55K |
May 13
|
Scheduled
| ||||||
Theravance Inc
|
0
|
$32.21 | -$82,580.48 |
—
| 55K |
May 3
|
Scheduled
| ||||||
Theravance Inc
| -8.77K |
$19.95 | -$526,242.09 | -13.75% | 55K |
Apr 30
|
Scheduled
| ||||||
Theravance Inc
| -3.42K |
$22.10 | -$75,493.60 | -5.08% | 63.77K |
Feb 20
| |||||||
Theravance Inc
| 5K |
—
|
—
| +8.04% | 67.19K |
Feb 7
| |||||||
Theravance Inc
| -3.05K |
$21.08 | -$64,378.32 | -4.68% | 62.19K |
Nov 20
| |||||||
Theravance Inc
| 5K |
—
|
—
| +8.30% | 65.24K |
Oct 15
| |||||||
Theravance Inc
| -3.48K |
$27.50 | -$95,782.50 | -5.47% | 60.24K |
Aug 24
|
Scheduled
| ||||||
Theravance Inc
| -3.06K |
$27.01 | -$82,569.57 | -4.58% | 63.72K |
Aug 20
| |||||||
Theravance Inc
| -17.16K |
$17.90 | -$2,618,807.29 | -20.44% | 66.78K |
Aug 3
|
Scheduled
| ||||||
Theravance Inc
| -2.40K |
$20.33 | -$48,832.66 | -2.78% | 83.94K |
May 20
| |||||||
Theravance Inc
| -5.32K |
$18.54 | -$98,595.72 | -5.80% | 86.34K |
Feb 20
| |||||||
Theravance Inc
| 5K |
—
|
—
| +5.77% | 91.66K |
Feb 15
| |||||||
Theravance Inc
| -1.89K |
$22.34 | -$42,155.58 | -2.13% | 86.66K |
Nov 20
| |||||||
Theravance Inc
| -1.89K |
$17.50 | -$33,057.50 | -2.09% | 88.55K |
Aug 20
| |||||||
Theravance Inc
| -6.06K |
$17.45 | -$1,810,512.82 | -6.28% | 90.44K |
May 27 - May 31
| |||||||
Theravance Inc
| -1.88K |
$25.48 | -$47,978.84 | -1.91% | 96.5K |
May 20
| |||||||
Theravance Inc
|
0
|
$14.77 | -$695,358.63 |
—
| 98.38K |
Mar 15 - Mar 16
| |||||||
Theravance Inc
| -2.48K |
$22.50 | -$55,800.00 | -2.46% | 98.38K |
Feb 20
| |||||||
Theravance Inc
| 62.5K |
—
|
—
| +162.93% | 100.86K |
Feb 11
| |||||||
Theravance Inc
| -4.72K |
$14.09 | -$454,047.50 | -10.97% | 38.36K |
Dec 1
| |||||||
Theravance Inc
| -1.77K |
$22.52 | -$39,792.84 | -3.94% | 43.08K |
Nov 20
| |||||||
Theravance Inc
| 12.5K |
—
|
—
| +38.64% | 44.85K |
Oct 26
| |||||||
Theravance Inc
| -1.98K |
$15.12 | -$29,937.60 | -5.77% | 32.35K |
Sep 14
| |||||||
Theravance Inc
| -907.00 |
$14.00 | -$12,698.00 | -2.57% | 34.33K |
Aug 20
| |||||||
Theravance Inc
|
0
|
$12.04 | -$470,899.80 |
—
| 35.24K |
Jun 14 - Jun 15
| |||||||
Theravance Inc
| -908.00 |
$13.02 | -$11,822.16 | -2.51% | 35.24K |
May 20
| |||||||
Theravance Inc
| -401.00 |
$10.22 | -$4,098.22 | -1.10% | 36.15K |
Feb 20
| |||||||
Theravance Inc
| 25K |
—
|
—
| +216.51% | 36.55K |
Feb 10
| |||||||
Theravance Inc
| -1.96K |
$13.01 | -$25,447.56 | -14.49% | 11.55K |
Dec 16
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.